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ABSTRACT
Objectives: The objective of the present systematic review was to test the hypothesis of no difference in implant treatment 
outcome after horizontal ridge augmentation with allogeneic bone block compared with autogenous bone block.
Material and Methods: A MEDLINE (PubMed), Embase and Cochrane Library search in combination with a hand-search 
of relevant journals was conducted including human studies published in English through March 13, 2019. Comparative and 
non-comparative studies evaluating horizontal ridge augmentation with allogeneic bone block were included. Cochrane risk 
of bias tool and Newcastle-Ottawa Scale were used to evaluate risk of bias.
Results: One comparative study with high quality and 12 non-comparative studies fulfilled the inclusion criteria. Considerable 
heterogeneity prevented meta-analysis from being performed. The comparative retrospective short-term study demonstrated no 
significant difference in implant treatment outcome between the two treatment modalities. Non-comparative long-term studies 
revealed high implant survival, gain in alveolar ridge width and bone regeneration with allogeneic bone block. However, non-
comparative studies disclosed high incidence of complications including dehiscence, exposure of allogeneic bone block and 
partial or total loss of the grafts.
Conclusions: There seemed to be no difference in implant treatment outcome after horizontal ridge augmentation with 
allogeneic bone block compared with autogenous bone block. However, increased risk of complications was frequently 
reported with allogeneic bone block.
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INTRODUCTION
Alveolar ridge deficiency following tooth loss 
compromises oral rehabilitation with implants [1]. 
Horizontal alveolar ridge augmentation (HARA) prior 
to implant placement is frequently necessary when 
dimensions of the alveolar process are inadequate 
[2-4]. 
Autogenous bone block is considered the preferred 
treatment modality for HARA with high survival rates 
of suprastructures and implants [5-10]. However, use 
of autogenous bone block is associated with risk of 
donor site morbidity, unpredictable graft resorption 
and possibility of injury to vital structures [11-
13]. Allogeneic bone block has been proposed as 
an alternative in HARA to diminish morbidity and 
simplify the surgical procedure. 
Allogeneic bone graft material derived from 
genetically non-identical donor of the same species 
is available as blocks (cortical, cancellous) or as 
chips or granules (cortical, cancellous). The most 
commonly used allogeneic bone graft materials are 
freeze-dried bone allograft (FDA), demineralized 
freeze-dried bone allograft (DFDA), and fresh-frozen 
bone allograft (FFA). Systematic reviews and meta-
analyses have concluded that allogeneic bone graft 
is a suitable grafting material [14,15]. However, 
allogeneic bone graft is rarely used for HARA 
compared with autogenous bone graft or other bone 
substitutes due to risk of immunologic reactions and 
disease transmission. 
HARA with allogeneic bone block has previously 
been assessed in systematic reviews and meta-
analyses reporting high implant survival rates 
and gain in alveolar ridge width [16,17]. A recent 
systematic review concluded insufficient evidence 
is available to establish treatment efficacy relative 
to graft incorporation, alveolar ridge augmentation, 
and long-term implant survival after HARA with 
allogeneic bone block [18]. Moreover, a radiographic 
and histomorphometric study assessing HARA 
with allogeneic bone block disclosed statistically 
significant less vital bone and more graft resorption 
compared with autogenous bone block graft 
after 6 - 8 months [19], in accordance with other 
publications revealing significant more resorption 
of the augmented area, low rate of graft remodelling 
and clear signs of inflammation with allogeneic 
bone block [20-23]. Furthermore, HARA with 
allogeneic bone block revealed significantly less vital 
mineralized bone compared with allogeneic bone 
block impregnated with autologous bone marrow [24]. 
Therefore, implant treatment outcome after HARA 
with allogeneic bone block compared with autogenous 
bone block graft involving clinical, radiographic and 
histomorphometric outcome measures is presently 
unknown. The objective of the present systematic 
review was to test the hypothesis of no difference in 
implant treatment outcome after horizontal alveolar 
ridge augmentation with allogeneic bone block 
compared with autogenous bone block. 
MATERIAL AND METHODS
Protocol and registration
 
Review was conducted in accordance with the 
Preferred Reporting Items for Systematic reviews and 
Meta-Analyses (PRISMA) statement for reporting 
systematic reviews [25]. Methods of the analysis 
and inclusion criteria were specified in advance 
and documented in a protocol and registered in 
PROSPERO, an international prospective register of 
systematic reviews. 
Registration number: CRD42019129754.
The protocol can be accessed at:
https://www.crd.york.ac.uk/prospero/display_record.
php?ID=CRD42019129754.
Focus question
Focus question was developed according to the 
Patient, Intervention, Comparison and Outcome 
(PICO) framework as described in Table 1. 
Eligibility criteria
Randomized controlled trials, controlled clinical 
trials, case-series and retrospective human studies 
assessing implant treatment outcome after HARA 
with allogeneic bone block compared with autogenous 
bone block were included in this study. Human studies 
solely evaluating HARA with allogeneic bone block 
were included as non-comparative studies.
Types of outcome measures
• Survival of suprastructures. Estimated by 
subtracting of failed suprastructures, which is 
defined as a complete loss of the suprastructure 
due to technical and/or biological complications.
• Survival of implants. Estimated by subtracting 
of failed implants, which is defined as mobility 
of previously clinically osseointegrated implants 
or removal of non-mobile implants due to 
progressive peri-implant marginal bone loss and 
infection.
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• Implant stability. Estimated by magnetic 
resonance frequency analysis, percussion test or 
reverse torque test.
• Bone-to-implant contact. Estimated by 
histomorphometric measurements.
• Peri-implant marginal bone loss. Evaluated by 
radiographic measurements.
• Histomorphometric assessment of new bone 
formation, residual allogeneic bone graft and 
connective tissue.
• Gain in alveolar ridge width and volumetric 
reduction of the augmented area. Estimated by 
clinical or radiographic measurements.
• Patient-reported outcome measures.
• Biologic and technical complications.
Information sources
The search strategy incorporated examinations of 
electronic databases, supplemented by a thorough 
hand-search page by page of relevant journals 
including “British Journal of Oral and Maxillofacial 
Surgery”, “Clinical Implant Dentistry and Related 
Research”, “Clinical Oral Implants Research”, 
“European Journal of Oral Implantology”, “Implant 
Dentistry”, “International Journal of Oral and 
Maxillofacial Implants”, “International Journal of 
Oral and Maxillofacial Surgery”, “International 
Journal of Periodontics and Restorative Dentistry”, 
“International Journal of Prosthodontics”, “Journal 
of Clinical Periodontology”, “Journal of Dental 
Research”, “Journal of Oral Implantology”, “Journal 
of Oral & Maxillofacial Research”, “Journal of 
Periodontology”, “Journal of Prosthetic Dentistry”, 
“Journal of Craniofacial Surgery”, “Journal of 
Cranio-Maxillo-Facial Surgery”, “Journal of Oral 
and Maxillofacial Surgery”, “Periodontology 2000”, 
“Oral and Maxillofacial Surgery” and “Oral Surgery 
Oral Medicine Oral Pathology Oral Radiology”. The 
manual search also included the bibliographies of 
all articles selected for full-text screening as well as 
previously published reviews relevant for the present 
systematic review. One reviewer (T.S-J.) performed 
the search.
Search strategy
A MEDLINE (PubMed), Embase, and Cochrane 
Library search was conducted. Human studies 
published in English through March 13, 2019 were 
included. Grey literature, unpublished literature as 
well as other databases like Scopus, Google Scholar, 
or Research Gate were not included in the search 
strategy of the present systematic review. Search 
strategy was performed in collaboration with a 
librarian and utilized a combination of Medical 
subject heading (MeSH) and free text terms. A 
detailed description of the search strategy is presented 
in Appendices 1, 2, 3 and 4.
Selection of studies
PRISMA flow diagram presents an overview of 
the selection process (Figure 1). Titles of identified 
reports were initially screened with duplicates 
removed. Abstracts were assessed when titles 
indicated that the study was relevant. Full-text 
analysis was obtained for those with apparent 
relevance or when the abstract was unavailable. 
References of papers identified and previously 
published systematic reviews assessing HARA 
with allogeneic bone block were cross-checked for 
unidentified articles. Study selection was performed 
by one reviewer (T.S-J.). 
Table 1. PICOS guidelines
Patient and 
population (P) Healthy patients with a horizontal alveolar deficiency following tooth loss or congenitally missing tooth/teeth.
Intervention (I) Horizontal alveolar ridge augmentation with an allogeneic bone block graft.
Comparator or 
control group (C) Horizontal alveolar ridge augmentation with autogenous bone block graft.
Outcomes (O)
Survival of suprastructure, implant survival rate, implant stability, bone-to-implant contact, peri-implant marginal 
bone loss, histomorphometric assessment of new bone formation, residual allogeneic bone graft and connective tissue, 
gain in alveolar ridge width and volumetric reduction of the augmented area, patient-reported outcome measures, 
biologic and technical complications.
Study design (S)
Randomized controlled trials, controlled clinical trials, case-series and retrospective studies assessing horizontal 
alveolar ridge augmentation with an allogeneic bone block graft compared with autogenous bone block graft. 
Moreover, human studies solely assessing horizontal alveolar ridge augmentation with allogeneic bone block graft 
was included as non-comparative studies.
Focused question Are there any differences in implant treatment outcome after horizontal alveolar ridge augmentation with an allogeneic bone block graft compared to autogenous bone block graft?
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Inclusion criteria
Studies assessing implant treatment outcome after 
HARA with allogeneic bone block compared with 
autogenous bone block were included by addressing 
the previously described outcome measures. Review 
exclusively focused on studies using HARA with 
block graft and lag-screw fixation prior to implant 
placement with an observation period after implant 
loading of at least six months. In addition, at least ten 
patients should be included and number of implants 
inserted and surgical procedures had to be clearly 
specified. 
Exclusion criteria
Following exclusion criteria were applied: unspecified 
length of observation period, insufficient description 
of surgical procedures or inserted implants as 
well as studies involving medically compromised 
patients. Likewise, HARA with allogeneic bone 
graft material in combination with a thermoplastic 
carrier, simultaneous implant placement, use of 
tunnel or tent pole techniques or titanium-reinforced 
membranes as well as studies adding growth factors, 
bone morphogenetic proteins, fibrin glue or platelet-
rich plasma to the grafting material were also 
excluded. Moreover, letters, editorials, PhD theses, 
letters to the editor, case reports, abstracts, technical 
reports, conference proceedings, cadaveric studies, 
animal or in vitro studies and literature review papers 
were excluded.
Data extraction
Data were extracted by one reviewer (T.S-J.) according 
to a data-collection form ensuring systematic 
recording of the outcome measures. In addition, 
relevant characteristics of the study were recorded. 
Corresponding authors were contacted by e-mail in the 
absence of important information or ambiguities.
Data items
Following items were collected and arranged in 
following fields: author, patients, pre-operative 
alveolar ridge width, study design, surgical site, type 
of grafting material, graft healing period, number of 
implants inserted, implant healing period, prosthetics, 
observation period after functional loading, 
suprastructure and implant survival, implant stability, 
bone-implant-contact, peri-implant marginal bone 
loss (PIMBL), histomorphometric measurements, 
gain in alveolar ridge width, patient-reported 
outcome measures (PROM), biologic and technical 
complications. 
Figure 1. PRISMA flow diagram demonstrating the results of systematic literature search. Electronic search resulted in 243 entries. Twenty-
four additional articles were identified through hand-searching. Of these 267 articles, 91 were excluded because they had been retrieved in 
more than one search. A total of 54 abstracts were reviewed and full-text analysis included 28 articles. Thirteen studies were finally included 
comprising one comparative study and 12 non-comparative studies.
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Quality and risk of bias assessment
Quality assessment was undertaken by one review 
author (T.S-J.) as part of the data extraction process. 
Cochrane Collaboration’s tool for assessing the risk 
of bias suggested in the Cochrane Handbook for 
Systematic Reviews of Interventions was used for 
included randomized controlled trials (version 5.1.0) 
[26].
Following items were evaluated:
• Random sequence generation;
• Allocation concealment;
• Patient blinding;
• Outcome blinding;
• Incomplete outcome data addressed;
• Selective reporting.
Publications were grouped into the following 
categories [27]:
• Low risk of bias (possible bias not seriously 
affecting results) if all criteria were met;
• High risk of bias (possible bias seriously 
weakening reliability of results) if one or more 
criteria were not met;
• Unclear risk of bias when too few details were 
available for classification as high or low risk.
Newcastle-Ottawa scale was applied for non-
randomized studies to judge each included study on 
selection of studies, comparability of cohorts, and 
the ascertainment of either the exposure or outcome 
of interest [28]. Stars were awarded with highest 
quality studies awarded up to nine stars. Included non-
randomized studies were categorized:
• Low-quality (0 - 3 stars);
• Moderate quality (4 - 6 stars);
• High quality (7 - 9 stars).
Quality assessment of included non-comparative 
studies was not conducted, as these studies were 
assumed to be associated with high risk of bias.
Statistical analysis
Parametric data involving PIMBL, gain in alveolar 
ridge width, volumetric reduction of the augmented 
area and histomorphometric measurements are 
presented as mean and standard deviation (M [SD]).
RESULTS 
Study selection
Search results are outlined in Figure 1. Electronic 
search resulted in 243 entries. Twenty-four additional 
articles were identified through hand-searching. 
Of these 267 articles, 91 were excluded due to 
being retrieved in more than one search. A total of 
54 abstracts were reviewed and full-text analysis 
included 28 articles. Finally, one comparative [29], 
and 12 non-comparative studies were included 
[30-41].
Exclusion of studies
Reasons for excluding 15 studies after full-text 
assessment were: study could not be excluded 
before meticulous reading (n = 1) [42], unspecified 
augmentation procedure (n = 1) [43], unspecified 
number of implants inserted (n = 1) [44], barrier 
membrane saturated in platelet-rich plasma (n = 1) 
[45], immediate implant placement (n = 1) [46], 
outcome measures could not be identified for 
HARA in studies involving both horizontal and 
vertical alveolar ridge augmentation (n = 2) [47,48], 
observation period after functional loading of six 
months not fulfilled (n = 3) [49-51], or observation 
period not clearly specified (n = 4) [52-56]. 
Study characteristics
Studies included in the present systematic review 
consisted of one comparative retrospective 
radiographic evaluation [29], and 12 non-comparative 
case-series [30-41]. Partial and totally edentulous 
patients with horizontal alveolar ridge deficiencies 
of the maxilla and mandible were enrolled. The 
comparative study was performed in accordance 
with STROBE guidelines and described power 
calculation of the sample size [29]. Age and gender 
distribution as well as inclusion criteria and exclusion 
criteria were specified in all included studies. 
Alveolar deficiency was defined according to ITI-
treatment guide categories [29], Cawood and Howell 
classification [33,37], Kennedy classification [41], 
or not specified [30-32,34-36,38-40]. Preoperative 
width of the alveolar ridge was specified in six non-
comparative studies [31-34,38,39]. No significant 
difference in patient demographics was reported in 
the comparative study [29]. The surgical procedure 
was performed by the same surgeon in two studies 
[37,40], by two surgeons in two studies [36,38], and 
by an unknown number in eight studies [29-35,39]. 
HARA was performed under local anaesthetics 
in 10 studies [29-31,33-36,38-40], under general 
anaesthesia in two studies [34,37], and was not 
reported in one study [32]. Implant placement was 
performed under local anaesthesia [29-31,33,35,36-
38], general anaesthesia [37], or no information 
was provided about the method used [32,34,39]. 
FDA bone block was used in the comparative study 
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(Maxgraft® - Botiss Biomaterials GmbH; Zossen, 
Germany) [29], and two non-comparative studies 
(ReadiGraft® Canblock - LifeNet Health, Inc.; 
Virginia Beach, Virginia, USA) [31,35]. DFDA 
bone block was used in one non-comparative 
study (OsteoGraft® - Argon Medical Devices Inc; 
Erlangen, Germany) [38]. FFA bone block from 
various tissue banks was used in six non-comparative 
studies including Clinics Hospital Tissue Bank of 
Universidade Federal do Parana, Curitiba, Brazil 
[30], Banca dei tessuti della Regione Veneto, Italy 
[33], Tissue Bank, Careggi Hospital, Florence, Italy 
[34], Gaetano Pini Orthopaedics Institute, Roma, 
Italy [37], Tissue Bank, Rio de Janeiro, Brazil [39], 
UNIOSS, Marilia, Brazil [40]. FDA bone block 
from Transplant Service Foundation, Sant Boi 
de LLobregat, Barcelona, Spain was used in one 
non-comparative study [36]. Origin of the used 
allogeneic bone block graft was not described in two 
non-comparative studies [32,41]. Native bone was 
perforated to ensure vascularization between recipient 
site and block graft [29-34,36-41]. Allogeneic bone 
block graft was covered by a barrier membrane 
in eight studies [29,31,32,35-37,40,41], while no 
membrane was used in four non-comparative studies 
[33,34,38,39]. Different implant systems were 
used including Biohorizons® (BioHorizons Inc; 
Birmingham, Alabama, USA) [36], BIOMET 3i® 
(BIOMET 3i LLC; Palm Beach Gardens, Florida, 
USA) [29,31], blueSKY™ (bredent medical Gmbh 
& Co.KG, Senden, Germany) [29], MIS implant (Mis 
Implant Technologies Ltd; Shlomi, Israel) [38], MIS 
Implant Technologies (Bar Lev Industries; Misgav, 
Israel) [31], Astra Tech OsseoSpeed®  (Dentsply 
Sirona; Göteborg/Mölndal, Sweden) [33,37], 
Osseogrip® (Plan 1. Health Srl; Amaro, UD, Italy) 
[33], PrimaConnex® (Keystone Dental, Inc.; Dallas, 
Texas, USA) [34], Straumann® (Straumann AG; Basal, 
Switzerland) [29,37], Systhex® (Systhex Sistema de 
Implantes Osseointegrados Ltda; Curitiba, Brazil) 
[30], CM  Titamax® Cortical (Neodent; Curitiba, 
Brazil) [40], and XiVE® (Dentsply Sirona; Göteborg/
Mölndal, Sweden) [37]. Implant system used was not 
specified in three non-comparative studies [32,35,39]. 
Dropouts were reported in two non-comparative 
studies [33,36]. None of the included studies provided 
information about examiner training or calibration.
Data synthesis
Meta-analyses were to be conducted only if there 
were studies of similar comparison, reporting identical 
outcome measures. However, studies included in 
the present systematic review revealed considerable 
variation in patient demographics, allogeneic bone 
block, barrier membrane, length of observation 
period, type of suprastructures and implants, 
dissimilar time frame between implant installation 
and prosthetic loading as well as different outcome 
measures. Therefore, a well-defined meta-analysis was 
not applicable.
Methodological quality
Quality of the included comparative study is 
summarized in Table 2. 
Outcome measures 
Results of HARA with allogeneic bone block 
compared with autogenous bone block are presented 
below and outlined in Table 3, followed by results 
of non-comparative studies in Table 4. All reported 
numerical values are presented as mean values. For 
each outcome measure, a summary is provided. 
Survival of suprastructures, implant stability, bone-to-
implant contact and PROM were not reported in any 
of the included studies. Thus, these outcome measures 
are not described in the following section or outlined 
in Table 3and 4.
Survival of implants
Comparative studies
Survival of implants after HARA with allogeneic 
bone block compared with autogenous bone block 
from ascending mandibular ramus was 100% 
for both treatment modalities, after 12 months 
[29].
Non-comparative studies
Survival of implants after HARA with allogeneic bone 
block varied between 90% and 100%, after 12 to 82 
months [30-41]. 
Table 2. Newcastle-Ottawa scale for assessing quality of non-randomized studies [28], categorized as low-quality 
(0 - 3 stars), moderate quality (4 - 6 stars), and high quality (7 - 9 stars)
Study Year ofpublication
Selection
(maximum 4 stars)
Comparability
(maximum 2 stars)
Outcome
(maximum 3 stars)
Total score/
quality
Kloss et al. [29] 2018 ☆ ★ ★ ★ ★ ★ ★ ★ ★ 8 stars/high quality
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Table 3. Horizontal alveolar ridge augmentation with allogeneic bone block graft compared with autogenous bone block graft
Study Studydesign
Outcome measures
Patients ARW(mm) Site Graft/N
GH
(months) Implant
IH
(months) Prosthetics
OP
(months)
Implant 
survival 
(%)
GARW (mm)/
VRAA (%)
BCTPO 6 months 12 months
Mean (SD) Mean (SD) Mean (SD)
Kloss et al. [29] Retrospectivestudy
21
NR NR
Mandible
ramus: 21 6
21
6 Single-crown 6 100
5.6 (1.5) 5.2 (1.6)/5.3 (6.2) 5.1 (1.5)/6.3 (6.2)
None
21 FDA: 21 21 5.5 (1.5) 5.2 (1.4)/4.4 (7.1) 5.2 (1.4)/4.8 (7.2)
ARW = alveolar ridge width; BTC = biological and technical complications; FDA = freeze-dried bone allograft; GARW = gain in alveolar ridge width; GH = graft healing time; IH = implant healing time; N = number; NR = not 
reported; OP = observation period after functional implant loading; PO = postoperative; VRAA = volumetric reduction of the augmented area; SD = standard deviation.
Table 4. Horizontal alveolar ridge augmentation with allogeneic bone block graft
Study Year ofpublication
Study
design
Outcome measures
Patients ARW(mm) Site Graft/N
GH
(months) Implant
IH
(months) Prosthetics
OP
(months)
IS
(%)
PIMBL
(mm)
Histomorphometric
measurements (%)
GAW (mm)/
VRAA (%) BTC
Contar et al. [30] 2009 CS 15 NR Maxil FFA: 34 9 (8 - 11) 51 NR NR 24 - 35 100 NR NR NR GE: 1
Nissan et al. [31] 2011 CS 12 ≤ 3 Maxil mandible FDA: 19 6 21 0 - 6 Fixed prosthesis 13 - 60 95.2 No crestal bone loss beyond first thread NR
6 months GE: 4
Fistula: 15 (SD 0.5)
Nissan et al. [32] 2011 CS 24 ≤ 3 Mandible FDA: 34 6 85 3 Fixed prosthesis 12 - 66 95.3 NR
6 months 6 months
NRNBF RG CT
5.6 (SD 1)/5
40 (SD 28) 29 (SD 24) 27 (SD 21)
Orsini et al. [33] 2011 CS 10 1.5 - 2.8 Maxil FFA: 10 5 14 5 Single crowns 24 100 NR
6 months 5 months
TGL: 1
NBF 58 (SD 25) 4.6 (SD 0.5)
Acocella et al. [34] 2012 CS 16 2 - 4 Maxil FFA: 18 4 - 9 34 4 Fixed prosthesis 18 - 30 100 NR Non-vital bone: 62 (SD 12)
4 - 9 months
GE: 14.1 (SD 0.8)/
11.5 (0 - 30)
Nissen et al. [35] 2012 CS 40 ≤ 3 Maxil FDA: 60 6 83 3 Fixed prosthesis 14 - 82 98.8 NR
6 months
NR DH: 16NBF RG CT
33 (SD 18) 26 (SD 17) 41 (SD 2)
Novell et al. [36] 2012 CS 15 NR Maxil mandible FDA: 36 4 - 6 53 4 - 6 NR 12 - 60 100 NR NR NR GE: 1FG: 1
Chiapasco et al. [37] 2015 CS 19 ≤ 3 Maxil mandible FFA: NR 5 - 7 117 5 - 6 NR 20 - 32 90.2
12 months 24 months
NR NR
DH: 14
PGL: 5
TGL: 21.6 (SD 1.6) 1.9 (SD 1.4)
Aslan et al. [38] 2016 CS 11 < 5 Maxil mandible DFDA: 12 5 32 3 Fixed prosthesis 24 100 NR
5 months 5 months
NoneNBF RG CT
1.7 (SD 0.1)/5.4
40 (SD 25) 40 (SD 21) 19 (SD 15)
Deluiz et al. [39] 2016 CS 8 NR Maxil FFA: NR 4 - 6 268 4 Fixed prosthesis 12 94 NR NR NR
DH: 5
PGL: 4
TGL: 3
Silva et al. [40] 2017 CS 20 ≤ 6 Mandible FFA: 50 6 50 6 Single-crown 20 - 42 96 NR
6 months 12 months
GE: 6NBF RG CT
4 (SD 0.7)/41
32 (SD 1) 15 (SD 0) 54 (SD 1)
Chaushu et al. [41] 2019 CS 14 NR Mandible NR: 24 6 26 3 Mostly fixed prosthesis 12 - 54 100
No crestal bone loss 
beyond first thread
6 months
5 (SD 0.5)
GE:6
TGL: 2
PGL: 6
NBF RG CT
42 17 41
ARW = alveolar ridge width; BTC = biological and technical complications; CS = case series; CT = connective tissue; DFDA = demineralized freeze-dried bone allograft; DH = dehiscence; FDA = freeze-dried bone allograft; FFA = fresh-frozen bone allograft; FG = fracture graft; 
GAW = gain in alveolar ridge width; GE = graft exposure; GH = graft heling; IH = Implant healing; IS = implant survival; N = number; NBF = new bone formation; NR = not reported; OP = observation period after functional implant loading; PGL = partial graft loss; RG = residual graft; 
TGL = total graft loss; VRAA = volumetric reduction of the augmented area; SD = standard deviation.
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Summary
The comparative study revealed high short-term 
implant survival with both treatment modalities. 
Non-comparative studies disclosed high long-term 
implant survival after HARA with allogeneic bone 
block.
Peri-implant marginal bone loss
Non-comparative studies
PIMBL was 1.2 mm at implant loading increasing to 
1.6 and 1.9 mm, one year and two years after implant 
loading, respectively [37]. No crestal bone loss 
beyond the first implant thread was reported in two 
studies, after an observation period between 12 to 60 
months [31,41].
Summary
PIMBL after HARA with allogeneic bone block 
was estimated in one non-comparative study 
demonstrating a PIMBL of 1.9 mm, after two years of 
implant loading.
Histomorphometric measurements
Non-comparative studies
Histomorphometric analysis of bone samples after 
HARA with FDA revealed 33 to 40% new bone 
formation, 26 to 40% residual graft material and 
19 to 41% connective tissue, after six months 
[32,35]. DFDA showed 40% new bone formation, 
40% residual graft material and 19% connective 
tissue, after five months [38]. FFA disclosed 32 
to 58% new bone formation, 15% residual graft 
material and 54% connective tissue, after six 
months [33,40]. Non-vital bone volume after HARA 
with FFA was 62%, after four to nine months 
[34].
Summary
HARA with allogeneic bone block facilitated bone 
regeneration and new bone formation in non-
comparative studies. However, a high percentage of 
non-vital bone volume was reported after HARA with 
FFA.
Gain in alveolar ridge width and volumetric 
reduction of the augmented area
Comparative studies
Gain in alveolar ridge width was 5.5 mm immediately 
after HARA with allogeneic bone block and 5.6 mm 
with autogenous bone block [29]. Corresponding 
measurements after six and 12 months were 5.2 and 
5.2 mm with allogeneic bone block and 5.2 and 5.1 
mm with autogenous bone block, respectively. There 
was no statistically significant difference in gain 
in alveolar ridge width between the two treatment 
modalities at any time points [29]. 
HARA with allogeneic bone block revealed 4.4% 
and 4.8% volumetric reduction of the augmented 
area after six and twelve months, respectively [29]. 
Corresponding measurements for autogenous bone 
block were 5.3% and 6.3%. There was no statistically 
significant difference in volumetric reduction of the 
augmented area between the treatment modalities at 
any time points [29]. 
Non-comparative studies
Gain in alveolar ridge width was 5 mm after HARA 
with FDA, after six months [31]. Gain in alveolar 
ridge width was estimated by subtracting the initial 
clinical width of the alveolar ridge from clinical width 
at time of implant placement [31]. 
Gain in alveolar ridge width was 5.6 mm after 
HARA with FDA, after six months [32]. Method and 
location used in estimating gain in alveolar ridge 
width was not specified. A 5% volumetric reduction 
of the augmented area was observed, six months after 
HARA [32]. 
Gain in alveolar ridge width was 4.6 mm after HARA 
with FFA, after five months [33]. Gain in alveolar 
ridge width was measured with computed tomography 
by subtracting initial width of the alveolar ridge from 
width at time of implant placement [33].
Immediate gain in alveolar ridge width after HARA 
with FFA was 4.6 and 4.1 mm, after four to nine 
months [34]. Gain in alveolar ridge width was 
measured with calipers by subtracting initial width of 
the alveolar ridge from width at time of HARA and 
implant placement. A 11.5% volumetric reduction of 
the augmented area was observed, four to nine months 
after HARA [34].
Immediate gain in alveolar ridge width after 
HARA with FFA was 6.4 mm [40]. Corresponding 
measurements after six months and twelve months 
was 4.6 and 4 mm, respectively. Gain in alveolar 
ridge width was measured on cone beam computed 
tomography using linear measurements from head of 
the fixation screw as reference point by subtracting 
initial width of alveolar ridge from width at time 
of HARA, implant placement, and twelve months 
after functional implant loading. A 31% volumetric 
reduction of the augmented area was observed, after 
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six months, and an additional 10% after twelve 
months, respectively [40].
Summary
The comparative study disclosed no statistically 
significant difference in gain in alveolar ridge width 
and volumetric reduction of augmented area between 
the treatment modalities. Non-comparative short-term 
studies demonstrated gain in alveolar ridge width 
of 5 to 5.6 mm after HARA with FDA, and 4.6 mm 
with FFA. Substantial volumetric stability of the 
augmented area for implant placement was revealed in 
most of the non-comparative studies. 
Biologic and technical complications 
Comparative studies
No signs of infection, wound dehiscence, 
graft exposure, or other biologic and technical 
complications were reported with both treatment 
modalities [29]. 
Non-comparative studies
No biologic or technical complications were reported 
in one study [38]. Postoperative pain, oedema, 
bruising and haematomas have been described after 
HARA with allogeneic bone block [30,37,38]. Soft 
tissue dehiscence has been reported in three studies 
with incidence varying between 27% and 74% [35-
37], while incision line opening occurred in 80% 
[41]. Graft exposure has been reported in seven 
studies with incidence varying between 6% and 
74% [30,31,34,36,37,40,41]. Partial or total loss 
of allogeneic bone block caused by infection and/
or graft exposure have been reported in four studies 
[33,37,39,41]. Moreover, soft tissue dehiscence, graft 
exposure and loss of graft after implant placement 
and abutment connection was frequently observed in 
one study [37]. A statistically significant correlation 
between infection and graft loss was reported in one 
study [39]. Fracture of the allogeneic bone block was 
reported in one study [36]. 
Fistula in the marginal gingiva after crown 
cementation was described in one patient [31]. The 
fistula closed spontaneously after curettage in the 
gingival sulcus [31]. 
Summary
Frequency of short-term and long-term biologic 
complications including incision line opening, soft 
tissue dehiscence, graft exposure and partial or total 
loss of allogeneic bone block was high. Consequently, 
increased risk of biologic complications may 
compromise long-term implant survival after HARA 
with allogeneic bone block. 
DISCUSSION 
The objective of the present systematic review was 
to test the hypothesis of no difference in implant 
treatment outcome after HARA with allogeneic 
bone block compared with autogenous bone block. 
One comparative retrospective study with high 
quality [29], and 12 non-comparative studies [30-41] 
fulfilled inclusion criteria. Considerable heterogeneity 
among included studies prevented meta-analysis 
performance. Moreover, diversity of evaluation 
methods, dissimilar observation periods after implant 
loading and various methodological confounding 
factors posed serious restrictions to literature 
review in a quantitative systematic manner. Hence, 
conclusions drawn from the results of the present 
systematic review should be interpreted with caution.
Survival of suprastructures and implants are the 
most important measures for assessment of long-
term implant treatment outcomes. However, survival 
of suprastructure was not reported in any of the 
included studies. Survival of implant was reported in 
all included studies, but long-term studies assessing 
implant survival after HARA with allogeneic bone 
block compared with autogenous bone block is 
lacking. Long-term studies assessing HARA with 
autogenous bone block have demonstrated implant 
survival of 95.7% and 98.1%, after 10 years [6,7]. 
A non-comparative long-term study included in the 
present systematic review disclosed implant survival 
of 98.8%, after 14 to 82 months [35]. Consequently, 
long-term randomized controlled trials assessing 
survival of suprastructures and implants after HARA 
with allogeneic bone block compared with autogenous 
bone block are needed before one treatment modality 
may be considered superior to another. 
A newly published systematic review and meta-
analysis concluded that HARA maintains peri-implant 
health over time with low mucosal inflammatory 
changes and relatively small incidence of PIMBL [57], 
in accordance with previously published systematic 
reviews [58,59]. A criterion of successful implant 
treatment is PIMBL of less than 1 to 1.5 mm during 
the first year after implant loading and less than 
0.2 mm annually, which in turn corresponds to a 
maximum of 1.7 mm after two years and 3.3 mm after 
10 years [60,61]. PIMBL was estimated in one non-
comparative study demonstrating 1.6 mm PIMBL, 
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one year after implant loading increasing to 1.9 mm 
after two years, which is larger than the described 
implant success criterion [37]. Long-term studies 
assessing HARA with autogenous bone block have 
demonstrated limited PIMBL, in accordance with the 
success criterion [6,7]. A comparative study assessing 
horizontal and vertical augmentation of extremely 
atrophic edentulous maxilla’s with allogeneic bone 
block disclosed a statistically significant larger 
PIMBL with allogeneic bone block compared 
with autogenous bone block [47]. Allogeneic bone 
block disclosed 1.5 mm and 1.6 mm PIMBL, one 
and two years after implant loading, respectively. 
Corresponding measurements for autogenous bone 
block was 0.8 mm and 0.9 mm, respectively [47]. 
Consequently, HARA with allogeneic bone block 
seems to be associated with higher risk of PIMBL 
compared with autogenous bone block. However, 
long-term randomized controlled trials are needed to 
validate this assumption. 
A recent systematic review assessing the efficacy 
of various grafting materials in alveolar ridge 
augmentation demonstrated that the degree of bone 
formation within the grafted volume was 33% 
with allogeneic bone graft compared with 51% for 
autogenous bone graft, and 56% for mixtures of 
autogenous bone graft and other grafting materials 
[3]. The non-comparative studies revealed 32% to 
58% new bone formation after HARA with allogeneic 
bone block [32,33,35,38,40]. A randomized controlled 
trial assessing HARA with FFA demonstrated no 
statistically significant differences in calcified tissue, 
new bone formation and remaining graft material after 
four months compared with six months, indicating 
no beneficial effect of a healing period longer than 
four months prior to implant placement [56]. Amount 
of bone regeneration after HARA with allogeneic 
bone block compared with autogenous bone block 
has been previously assessed in controlled trials 
[19,62], and randomized controlled trials [20]. A 
statistically significant larger amount of vital bone 
was revealed after HARA with autogenous bone 
block compared with FFA, after six to eight months 
[19]. However, histomorphometric analysis of bone 
samples obtained after HARA with FFA revealed no 
statistically significant difference in percentage of 
lamellar bone and new bone formation compared with 
autogenous bone block, after seven to nine months 
[62]. Qualitative histologic analysis of biopsies 
obtained from allogeneic bone block frequently 
showed areas of non-viable bone, with empty lacunae 
and poor bone remodelling in the most distant 
portions from the recipient bed [62]. These results are 
in accordance with a non-comparative study of the 
present systematic review disclosing 62% non-vital 
bone volume after HARA with FFA [34]. Moreover, 
a randomized controlled trial assessing HARA with 
FFA compared with autogenous bone block revealed 
new bone formation with both treatment modalities, 
but FFA demonstrated clear signs of inflammation 
[20]. Similar healing patterns have been observed 
in an experimental study demonstrating statistically 
significant greater revascularization and bony 
replacement after HARA with autogenous bone 
block compared with allogeneic bone block [63]. 
Autogenous bone block was replaced by newly 
formed bone, whereas regions of non-vital bone were 
seen after HARA with allogeneic bone block [63]. 
Consequently, both treatment modalities seem to 
facilitate new bone formation. However, amount of 
bone regeneration after HARA with autogenous bone 
block seems to be enhanced compared with allogeneic 
bone block. 
HARA with use of a block graft is considered a 
highly predictable surgical technique for obtaining 
sufficient bone volume for delayed implant placement 
[3-5,9,10]. Gain in alveolar ridge width of more 
than 4 mm after HARA with autogenous bone block 
has previously been documented [4,64,65]. The 
comparative study of the present systematic review 
revealed equivalent gain in alveolar ridge width 
and volumetric stability of augmented areas with 
allogeneic bone block compared with autogenous 
bone block [29]. Most of the included non-
comparative studies revealed similar gain in alveolar 
ridge width and volumetric stability of the augmented 
area [31-34,38,41]. However, continued reduction 
of the augmented area was reported in one of the 
included non-comparative studies [40], in accordance 
with a randomized controlled trial measuring graft 
resorption at different time points after HARA with 
allogeneic bone block [50]. Computed tomography 
and three-dimensional measurements demonstrated 
mean graft resorption of 13% after four months, 
33% after six months, and 51% after eight months, 
respectively [50]. Moreover, randomized controlled 
trials using computed tomography and three-
dimensional measurements have shown statistically 
significant larger volumetric reduction of the 
augmented area after HARA with FFA compared with 
autogenous bone block [20,21]. In conclusion, HARA 
with allogeneic bone block seems to gain sufficient 
alveolar ridge width for delayed implant placement, 
but an unpredictable volumetric reduction of the 
augmented area evidently occurs during the healing 
phase. Studies included in the present systematic 
review used dissimilar clinical and radiographic two-
dimensional linear measurements for assessment 
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of gain in alveolar ridge width and volumetric 
reduction of the augmented area, which certainly 
incorporates measurements error. A bone block is an 
inhomogeneous and three-dimensional anisotropic 
structure and, therefore three-dimensional methods 
should be applied for studies assessing volumetric 
reduction of the augmented area. Therefore, 
conclusions of the present systematic review may 
be compromised by use of different measurement 
techniques and observation periods. Thus, further 
long-term randomized controlled trails should 
use standardized methods and three-dimensional 
volumetric measurements.
Biologic complications including soft tissue 
dehiscence, graft exposure, partial and total graft 
loss have been reported in a systematic review after 
HARA with autogenous bone block [59]. Moreover, 
temporary and permanent paraesthesia as well as gait 
disturbances have been described after harvesting 
autogenous bone graft in conjunction with HARA 
[47,62,66]. No biologic or technical complications 
were reported in the comparative study of the 
present systematic review [29]. However, a previous 
published study assessing HARA with allogeneic 
bone block reported dehiscence and graft exposure as 
well as partial and total loss of graft before and after 
implant placement compared with no complications 
after HARA with autogenous bone block [62]. 
Likewise, graft exposure and loss have been described 
after HARA with allogeneic bone block compared 
with no biologic complications with autogenous bone 
block [67]. High incidence of biologic complications 
including incision line opening, soft tissue dehiscence, 
graft exposure, partial or total loss of the allogeneic 
bone block were reported in some included non-
comparative studies [31,37,39-41] of the present 
systematic review. Similar observations have been 
described after HARA with allogeneic bone block 
[45,48,49]. Moreover, a comparative study assessing 
horizontal and vertical augmentation of extremely 
atrophic edentulous maxilla’s with allogeneic bone 
block graft disclosed increased soft tissue dehiscence, 
graft exposure and sequestration before and after 
implant placement with allogeneic bone block 
compared with autogenous bone block from the iliac 
crest [47]. Hence, HARA with allogeneic bone block 
seems to be associated with increased risk of biologic 
complications at the recipient site, which may 
compromise long-term implant survival. 
Allogeneic bone block use for HARA compared 
with harvesting autogenous bone block is associated 
with obvious advantages for patients. Consequently, 
comparison of the two treatment modalities 
should contain evaluation of donor site morbidity, 
inflammatory reactions, economic perspective, PROM 
and length of patient treatment time. However, these 
aspects have not been addressed in any of the included 
studies. 
CONCLUSIONS
The hypothesis of no difference in implant 
treatment outcome after horizontal alveolar ridge 
augmentation with allogeneic bone block compared 
with autogenous bone block could neither be 
confirmed nor rejected due to insufficient available 
knowledge. A comparative retrospective short-
term study revealed no statistically significant 
difference in implant treatment outcome between the 
two treatment modalities. Non-comparative long-
term studies demonstrated high implant survival, 
gain in alveolar ridge width and bone regeneration 
after horizontal alveolar ridge augmentation with 
allogeneic bone block. However, high incidence 
of biologic complications including soft tissue 
dehiscence, exposure of allogeneic bone block, partial 
or total loss of the block graft were reported in non-
comparative studies. Moreover, dissimilar evaluation 
methods, observation periods, outcome measures 
and various methodological confounding factors 
posed serious restrictions for literature review in a 
quantitative systematic manner. Hence, conclusions 
drawn from results of this systematic review should 
be interpreted with caution and further long-term 
randomized controlled trials including assessment 
of donor site morbidity, patient-reported outcome 
measures, economic perspective and patient treatment 
time are needed before definite conclusions can be 
provided about horizontal alveolar ridge augmentation 
with allogeneic bone block compared with autogenous 
bone block.
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Appendix 3. Embase search until the 13th of March, 2019
No. Query Results
#25 #16 AND #24 54
#24 #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 8348399
#23 ‘retrospective’:ti,ab,de OR ‘prospective’:ti,ab,de 1889391
#22 ‘prospective study’/exp 501191
#21 ‘retrospective study’/de 742766
#20 (((single OR double OR triple) NEAR/2 (blind* OR mask*)):ti,ab,de) OR placebo:ti,ab,de 553332
#19 (((random* OR controlled* OR crossover OR ‘cross over’ OR blind* OR mask*) NEAR/3 (trial* OR study OR studies OR analy*)):ti,ab,de) OR rct:ti,ab,de 7025700
#18 ‘randomized controlled trial’/exp 537166
#17 ‘controlled clinical trial’/exp 704690
#16 #6 AND #15 142
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#12 ‘freeze dry*’ OR ‘freeze drie*’ 28013
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#8 ‘allograft*’ 104671
#7 ‘allograft’/exp 39144
#6 #1 OR #2 OR #3 OR #4 OR #5 1046
#5 ‘horizontal ridge augment*’ 53
#4 ‘lateral ridge augment*’ 55
#3 ‘alveolar ridge augment*’ 931
#2 ‘alveolar augment*’ 70
#1 ‘alveolar ridge augmentation’/de 502
Appendix 4. Cochrane Library search until the 13th of March, 2019
ID Search Hits
#1 MeSH descriptor: [Alveolar Ridge Augmentation] explode all trees 283
#2 (alveolar ridge augment*):ti,ab,kw (Word variations have been searched) 362
#3 (alveolar augment*):ti,ab,kw 513
#4 (lateral ridge augment*):ti,ab,kw 50
#5 (horizontal ridge augment*):ti,ab,kw 74
#6 #1 or #2 or #3 or #4 or #5 527
#7 MeSH descriptor: [Allografts] explode all trees 139
#8 (allograft*):ti,ab,kw 3439
#9 (allogeneic* or allgenic*):ti,ab,kw 3727
#10 MeSH descriptor: [Cryopreservation] explode all trees 535
#11 (fresh frozen*):ti,ab,kw 1102
#12 MeSH descriptor: [Freeze Drying] explode all trees 184
#13 (freeze dry*):ti,ab,kw 288
#14 (freeze drie*):ti,ab,kw 514
#15 #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 8749
#16 #6 and #15 in Trials 72
